Scor SE (OTCMKTS:SCRYY – Get Free Report) has earned an average rating of “Hold” from the seven analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating on the company.
Several research firms have recently weighed in on SCRYY. BNP Paribas Exane lowered shares of Scor from an “outperform” rating to a “neutral” rating in a report on Wednesday, June 17th. UBS Group lowered shares of Scor from a “hold” rating to a “sell” rating in a research report on Tuesday, August 18th.
Read Our Latest Analysis on Scor
Scor Price Performance
Scor (OTCMKTS:SCRYY – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The financial services provider reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.02. The firm had revenue of $4.17 billion during the quarter, compared to analyst estimates of $4.25 billion. Scor had a return on equity of 19.18% and a net margin of 5.50%. On average, research analysts anticipate that Scor will post 0.49 earnings per share for the current year.
About Scor
SCOR SE is a France-based global reinsurance company that provides risk-transfer solutions to insurance companies and other institutional clients. Its business is organized primarily around two areas: property and casualty reinsurance, and life and health reinsurance.
Through its property and casualty operations, SCOR offers coverage for risks including natural catastrophes, specialty lines, commercial property, liability, motor and other insurance exposures. Its life and health activities support insurers with solutions related to mortality, longevity, disability, medical and other protection risks, as well as financial and capital-management needs.
SCOR serves clients across major insurance markets in Europe, North and South America, and the Asia-Pacific region.
Featured Stories
- Five stocks we like better than Scor
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Scor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scor and related companies with MarketBeat.com's FREE daily email newsletter.
